Shikonin modulates ROS to cause iron death in cancer cells, and Ni et al. (2023) found that shikonin conjunction with cisplatin overcame drug resistance in cancer cells, downregulated GPX4, and upregulated haemoglobin oxygenase 1 (HMOX1) inducing iron death in cells. This evidence concerns the gene HMOX1 and cancer.